|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
University of Washington |
| Information provided by: | University of Washington |
| ClinicalTrials.gov Identifier: | NCT00663533 |
Purpose
The purpose of this research study is to study an experimental vasectomy device called the Vas-X. This is an experimental study of this new approach to vasectomy.
| Condition | Intervention | Phase |
|
Healthy |
Device: Vas-X |
Phase I |
| Study Type: | Interventional |
| Study Design: | Prevention, Open Label, Active Control, Single Group Assignment, Safety/Efficacy Study |
| Official Title: | Vasectomy With the Vas-X, a Simple, Minimally Invasive Device for Male Sterilization: A Pilot Study |
| Enrollment: | 12 |
| Study Start Date: | April 2008 |
| Estimated Study Completion Date: | June 2010 |
| Estimated Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
The Vas-X works by stripping the lining of the vas deferens, the tube that sperm pass through during ejaculation. It is used in a way very similar to routine vasectomy, however, in a routine vasectomy, the vas is burned with an electrical device. With the Vas-X, there is no burning. We are testing the Vas-X to determine whether it will offer a better way of performing a vasectomy.
We will conduct this study at the University of Washington Medical Center, Seattle.
Eligibility
| Ages Eligible for Study: | 30 Years to 55 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Men with past history of
Contacts and Locations| United States, Washington | |||||
| University of Washington | |||||
| Seattle, Washington, United States, 98195 | |||||
| University of Washington |
| Principal Investigator: | John Amory | University of Washington |
More Information
The Center for Research in Reproduction and Contraception is dedicated to basic and clinical research focused primarily on the male reproductive system. 
  |
| Responsible Party: | University of Washington ( John K Amory, MD, MPH ) |
| Study ID Numbers: | 32431 |
| First Received: | April 18, 2008 |
| Last Updated: | August 5, 2008 |
| ClinicalTrials.gov Identifier: | NCT00663533 |
| Health Authority: | United States: Food and Drug Administration |
|
|